OBJECTIVE: While schizophrenia has long been considered a disorder of brain connectivity, few studies have investigated white matter abnormalities in patients with first-episode schizophrenia, and even fewer studies have investigated whether there is progressive white matter pathology in the disease. METHOD: The authors obtained a T1-weighted structural magnetic resonance imaging (MRI) scan on 41 patients with first-episode schizophrenia. These first-episode schizophrenia patients were analyzed relative to 47 age- and sex-matched healthy comparison subjects who also underwent an MRI scan. Of the baseline participants, 25 first-episode schizophrenia patients and 26 comparison subjects returned 2 to 3 years later for a follow-up scan. To identify regional volumetric white matter differences between the two groups at baseline, voxel-based morphometry in statistical parametric mapping-2 (SPM2) was used, while tensor-based morphometry was used to identify the longitudinal changes over the follow-up interval. RESULTS: The first-episode schizophrenia patients exhibited volumetric deficits in the white matter of the frontal and temporal lobes at baseline, as well as volumetric increases in the white matter of the frontoparietal junction bilaterally. Furthermore, these first-episode schizophrenia patients lost considerably more white matter over the follow-up interval relative to comparison subjects in the middle and inferior temporal cortex bilaterally. CONCLUSIONS: These results indicate that patients with schizophrenia exhibit white matter abnormalities at the time of their first presentation of psychotic symptoms to mental health services and that these abnormalities degenerate further over the initial years of illness. Given the role that white matter plays in neural communication, the authors suggest that these white matter abnormalities may be a cause of the dysfunctional neural connectivity that has been proposed to underlie the symptoms of schizophrenia.
OBJECTIVE: While schizophrenia has long been considered a disorder of brain connectivity, few studies have investigated white matter abnormalities in patients with first-episode schizophrenia, and even fewer studies have investigated whether there is progressive white matter pathology in the disease. METHOD: The authors obtained a T1-weighted structural magnetic resonance imaging (MRI) scan on 41 patients with first-episode schizophrenia. These first-episode schizophreniapatients were analyzed relative to 47 age- and sex-matched healthy comparison subjects who also underwent an MRI scan. Of the baseline participants, 25 first-episode schizophreniapatients and 26 comparison subjects returned 2 to 3 years later for a follow-up scan. To identify regional volumetric white matter differences between the two groups at baseline, voxel-based morphometry in statistical parametric mapping-2 (SPM2) was used, while tensor-based morphometry was used to identify the longitudinal changes over the follow-up interval. RESULTS: The first-episode schizophreniapatients exhibited volumetric deficits in the white matter of the frontal and temporal lobes at baseline, as well as volumetric increases in the white matter of the frontoparietal junction bilaterally. Furthermore, these first-episode schizophreniapatients lost considerably more white matter over the follow-up interval relative to comparison subjects in the middle and inferior temporal cortex bilaterally. CONCLUSIONS: These results indicate that patients with schizophrenia exhibit white matter abnormalities at the time of their first presentation of psychotic symptoms to mental health services and that these abnormalities degenerate further over the initial years of illness. Given the role that white matter plays in neural communication, the authors suggest that these white matter abnormalities may be a cause of the dysfunctional neural connectivity that has been proposed to underlie the symptoms of schizophrenia.
Authors: Thomas J Whitford; Marek Kubicki; Shahab Ghorashi; Jason S Schneiderman; Kathryn J Hawley; Robert W McCarley; Martha E Shenton; Kevin M Spencer Journal: Neuroimage Date: 2010-10-25 Impact factor: 6.556
Authors: Päivikki Tanskanen; Khanum Ridler; Graham K Murray; Marianne Haapea; Juha M Veijola; Erika Jääskeläinen; Jouko Miettunen; Peter B Jones; Edward T Bullmore; Matti K Isohanni Journal: Schizophr Bull Date: 2008-11-17 Impact factor: 9.306
Authors: George Bartzokis; Po H Lu; Erika P Raven; Chetan P Amar; Nicole R Detore; Alexander J Couvrette; Jim Mintz; Joseph Ventura; Laurie R Casaus; John S Luo; Kenneth L Subotnik; Keith H Nuechterlein Journal: Schizophr Res Date: 2012-07-17 Impact factor: 4.939
Authors: Thomas J Whitford; Marek Kubicki; Paula E Pelavin; Diandra Lucia; Jason S Schneiderman; Christos Pantelis; Robert W McCarley; Martha E Shenton Journal: Schizophr Res Date: 2014-10-11 Impact factor: 4.939
Authors: Ponnada A Narayana; Sushmita Datta; Guozhi Tao; Joel L Steinberg; F Gerard Moeller Journal: Drug Alcohol Depend Date: 2010-05-31 Impact factor: 4.492
Authors: Serge A Mitelman; Emily L Canfield; Randall E Newmark; Adam M Brickman; Yuliya Torosjan; King-Wai Chu; Erin A Hazlett; M Mehmet Haznedar; Lina Shihabuddin; Monte S Buchsbaum Journal: Open Neuroimag J Date: 2009-05-20
Authors: Gary Price; Mara Cercignani; Elvina M Chu; Thomas R E Barnes; Gareth J Barker; Eileen M Joyce; Maria A Ron Journal: Neuroimage Date: 2009-07-23 Impact factor: 6.556